Keywords: fda, panel, backs, safety, b-ms/az, onglyza, expert

FDA panel backs safety of B-MS/AZ' Onglyza

Article | 02 April 2009

Print This

An expert panel convened by the US Food and Drug Administration has voted 10 to two that data on type 2 diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in